Investigation of Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders On September 16, 2019, Verrica announced it had submitted its New Drug Application (“NDA”) for VP-102 with the U.S. Food &
Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading Shareholders On September 16, 2019, Verrica announced it had submitted its New Drug Application (“NDA”) for VP-102 with the U.S. Food &
Exela Technologies Inc. (XELA) Accused of Misleading Shareholders In Exela’s 2017 and 2018 annual reports and in its first through third quarter 2019 reports, the Company attested to its
Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Fifth Third Bancorp (FITB) on Behalf of Shareholders July 13, 2020 (San Diego, CA & Cincinnati, OH) – Shareholder
Enphase Energy, Inc. (ENPH) Accused of Misleading Shareholders On March 15, 2019, Enphase filed its 2018 annual report touting revenue of $316.159 million and gross margins of 29.9%. As the
J2 Global, Inc. (JCOM) Accused of Misleading Shareholders Throughout the relevant period, J2 Global affirmed that it had disclosed all of its related-party transactions as required by the SEC
CURO Group Holdings, Corp. (CURO) Faces Liability for Misleading Shareholders About FY 2018 Guidance According to the class action complaint filed against CURO Group Holdings, Corp., although CURO was accelerating
Wirecard AG (WCAGY, WRCDF) Accused of Misleading Shareholders Throughout the relevant period Wirecard had represented that its consolidated financials accurately reflected its cash balances and revenue. However, on June
Sorrento Therapeutics, Inc. (SRNE) Accused of Misleading Investors On May 15, 2020, Sorrento announced that it had discovered an antibody that had “demonstrated 100% inhibition of SARS-CoV-2 virus infection” and
Ideanomics, Inc. (IDEX) Accused of Misleading Shareholders In May 2020, Ideanomics touted that its Mobile Energy Global (“MEG”) center “in Qingdao now hosts a full suite of car dealer
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.